Category Archives: Proton Pump Inhibitors

Featured Stories

U.K. Regulators Issue Additional Guidance for Metal-on-Metal Hip Implant Recipients

Regulators in the U.K. are once again issuing advice to doctors and other healthcare professionals involved in the follow-up of patients with metal-on-metal hip replacement devices. In an alert issued by the Medicines and Healthcare products Regulatory Agency (MHRA), guidance is provided for four groups of metal-on-metal hip implant ...

Read More

New Study Links Metal-on-Metal Hip Replacement Corrosion with Adverse Local Tissue Reactions

Yet another study is pointing to potential dangers posed by metal-on-metal hip implants. This time, an article published in the Journal of Arthroplasty is reporting corrosion in the head taper junction was more likely to occur in patients with 36-mm diameter metal-on-metal hip replacement, compared to those with the same ...

Read More

Parker Waichman Representing Another Louisiana Plaintiff in Actos Bladder Cancer Lawsuit

A Louisiana man has become the latest to claim that his taking the type 2 diabetes drug Actos resulted in developing bladder cancer. He has filed a lawsuit against the Japanese manufacturer of the drug and the marketer of it in the U.S., claiming they failed to warn about this ...

Read More

Lawsuits over DePuy ASR Metal-on-Metal Hip Implants Continue to Mount

DePuy Orthopaedics and its parent, Johnson & Johnson, continue to be hit with lawsuits over recalled metal-on-metal DePuy ASR hip implants. Just yesterday, the national law firm of Parker Waichman LLP announced it had filed yet another DePuy ASR hip implant lawsuit, this time on behalf of a Virginia resident ...

Read More

Louisiana Whistleblower Lawsuit Revived

Louisiana Whistleblower Lawsuit Revived

A state appeals court in Louisiana has ruled that a former employee of Rapides Parish Coliseum can proceed with a whistleblower lawsuit against the Coliseum Authority.

Read More

Toxic Nano-Particles from Failing Metal-on-Metal Hip Replacements May Pose Long-Term Health Risks

According to a new study, failing metal-on-metal hip implants generate toxic nano-particles that release Cobalt 2+ ions, which not only cause inflammation in surrounding tissue, but have the potential to cause long-term damage to the genetic material of cells. According to a report published by Medicalxpress.com, this “genotoxicity” could ...

Read More

Pennsylvania Health System Proposes Comprehensive Fracking Study

A proposed study would examine the health effects of hydraulic fracturing (fracking) drilling on the people living closest to active natural gas wells.

Read More

EMA Seeks Stronger Pradaxa Guidance for Bleeding Side Effects

Regulators in Europe have again asked Boehringer Ingelheim, the manufacturer of the blood thinner Pradaxa, to update the drug’s label with additional information regarding Pradaxa bleeding side effects. According to the European Medicines Agency (EMA), the new guidance should include more specific information on when Pradaxa must not be used, ...

Read More

Estate of Kentucky Man Alleges Wrongful Death Due to Actos Bladder Cancer

National law firm, Parker Waichman LLP, just filed a lawsuit on behalf of the estate of a Kentucky man who developed bladder cancer and subsequently died, allegedly due to the use of diabetes drug, Actos. The lawsuit names Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals USA, Inc., Takeda Pharmaceuticals North America, ...

Read More

Hip Replacement, Knee Implant Patients with Diabetes, Other Health Problems May Face Difficult Recoveries

Patients receiving hip replacement devices or knee implants may face a more complicated recovery if they are obese, or suffer from diabetes or other health woes. According to a new study published online in the journal Anesthesiology, at least 3% of all total hip or knee replacement patients will ...

Read More

Popular Heartburn Medications Linked to Increased Risk of Death

Drugs to relieve heartburn and acid-reflux are among the best selling drugs in the country, used by millions of Americans annually in both prescription and non-prescription strength. Excess acid can cause stomach ulcers and damage to the esophagus. A reduction … Continue reading

Posted in Health Concerns, Pharmaceuticals, Proton Pump Inhibitors |

Popular Acid Reflux Medication Nexium Linked to Kidney Issues

Acid Reflux Medication Nexium Linked to Kidney Issues

Recent revelations about Nexium have uncovered kidney side effects in one of the most frequently prescribed treatments for excess stomach acid. Nexium is the brand name for esomeprazole, manufactured by Astra Zeneca. Nexium conditions such as gastroesophageal reflux or Zollinger-Ellison … Continue reading

Posted in Nexium, Pharmaceuticals, Proton Pump Inhibitors | Tagged , , , , , , , , , |

Nexium, Other PPIs and the Risk of Kidney Side Effects

Nexium, Other PPIs and the Risk of Kidney Side Effects

Nexium, Prilosec and Prevacid are part of a class of medications known as proton pump inhibitors (PPIs). They are used to relieve heartburn and acid reflux by lowering the amount of acid produced by the stomach. Recent studies suggest that … Continue reading

Posted in Nexium, Pharmaceuticals, Proton Pump Inhibitors | Tagged , , , , , , , , , , , |

Research Suggests Long-Term PPI Use is Linked to Kidney Damage

Research Suggests Long-Term PPI Use Linked to Kidney Damage

Two studies published this year evaluated the risk of kidney damage associated with proton pump inhibitors (PPIs). PPIs, which treat heartburn and acid reflux by lowering the amount of stomach acid produced, include Prilosec, Nexium and Prevacid. The studies suggest … Continue reading

Posted in Nexium, Pharmaceuticals, Proton Pump Inhibitors | Tagged , , , , , , , , , , , , , , , |

Increased Dementia Risk Linked to Heartburn Drugs Linked to Use of Proton Pump Inhibitors for Heartburn

New research suggests that the use of certain drugs for gastric reflux or peptic ulcers creates an increased risk for dementia in elderly patients. The class of drugs—proton pump inhibitors (PPIs)—includes Prevacid (lansoprazole), Nexium (esomeprazole), and Prilosec (omeprazole), HealthDay reports.

Posted in Defective Products, Health Concerns, Nexium, Pharmaceuticals, Proton Pump Inhibitors |

Widely Used Heartburn Drugs Linked to Increased Risk for Dementia

Researchers say repeated use certain drugs for gastric reflux or peptic ulcers is linked to a higher risk for dementia among patients in Germany. The class of drugs—proton pump inhibitors (PPIs)—includes Prevacid (lansoprazole), manufactured by Novartis, Nexium (esomeprazole) and Prilosec … Continue reading

Posted in Health Concerns, Pharmaceuticals, Proton Pump Inhibitors |

Common Heartburn Drugs May Increase Risk for Kidney Disease

Proton-pump-inhibitors

Proton pump inhibitors (PPIs)—widely used heartburn medicines—may increase the risk for kidney disease. PPIs are sold under brand names, including Nexium, Prevacid and Prilosec, in both prescription and over-the-counter formulas. Proton pump inhibitors (PPIs) greatly reduce the amount of acid … Continue reading

Posted in Health Concerns, Pharmaceuticals, Proton Pump Inhibitors | Tagged , , , , , |

Study Shows Proton Pump Inhibitors May Increase Heart Attack Risk

Proton Pump Inhibitors May Increase Heart Attack Risk

  A data-mining study published on June 10 in PLOS One shows that people who take proton pump inhibitor drugs for gastroesophageal reflux disease (GERD) are at increased risk for heart attacks. The study evaluated data for 2.9 million patients … Continue reading

Posted in Health Concerns, Pharmaceuticals, Proton Pump Inhibitors | Tagged , , , |

Stomach Acid Medications May Increase Risk of Vitamin Deficiency

stomach-aid-vitamin-deficiency

Some drugs widely used to control stomach acid may increase the risk of a serious vitamin deficiency, a new study suggests. A research team found that people who were diagnosed with vitamin B12 deficiency were more likely to be taking … Continue reading

Posted in Health Concerns, Nexium, Pharmaceuticals, Proton Pump Inhibitors |

Kidney transplant rejections higher among those prescribed PPI acid-blockers

A retrospective study of kidney transplant patients found that those taking Proton Pump Inhibitor (PPI) drugs in conjunction with another drug in the year after their surgery were more likely to experience rejection. According to a report at RenalandUrologyNews.com on … Continue reading

Posted in Pharmaceuticals, Proton Pump Inhibitors | Tagged , , |

© 2005-2018 Parker Waichman LLP ®. All Rights Reserved.